🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the influence of BI 187004 on kinetics of cytochrome P450 (CYP) a...
Status
Completed
Location
1307.19.1 Boehringer Ingelheim Investigational Site
Start Date
2014-10
Trial ID
NCT02254148
Treatments Being Tested
To investigate bioavailability of BI 187004 and of metformin after concomit...
Status
Completed
Location
1307.7.1 Boehringer Ingelheim Investigational Site
Start Date
2014-05
Trial ID
NCT02109679
To determine the relative bioavailability of an BI 187004 tablet formulatio...
Status
Completed
Location
1307.3.1 Boehringer Ingelheim Investigational Site
Start Date
2014-06
Trial ID
NCT02161432
To assess the influence of BI 187004 on pharmacokinetics of CYP2C8 and CYP2...
Status
Completed
Location
1307.20.1 Boehringer Ingelheim Investigational Site
Start Date
2014-12
Trial ID
NCT02305901
Treatments Being Tested
To investigate safety, tolerability, pharmacokinetics including dose propor...
Status
Completed
Location
1307.1.1 Boehringer Ingelheim Investigational Site
Start Date
2012-04
Trial ID
NCT01587417
Treatments Being Tested
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
1307.2.1 Boehringer Ingelheim Investigational Site
Start Date
2013-06
Trial ID
NCT01874483
Assess the safety and tolerability of once daily oral doses of BI 187004 in...
Status
Completed
Location
1307.4.49003 Boehringer Ingelheim Investigational Site
Start Date
2014-07
Trial ID
NCT02150824